World Cancer Day: The Technologies Advancing Cancer Research
4 Feb 2015
In honor of World Cancer Day 2015, SelectScience shares some of the recent advances in technologies and methods being used in cancer research. Watch videos and download application notes to learn about these technologies, which are assisting research for the prevention, diagnosis and treatment of cancer.
Prof. Jeremy Nicholson Introduces the MRC-NIHR Phenome Centre
Prof. Jeremy Nicholson, Chair in Biological Chemistry and Head of the Department of Surgery and Cancer at Imperial College London, introduces the MRC-NIHR Phenome Centre, a Waters Center of Innovation. Prof. Nicholson, who is also Lead Principal Investigator at the centre, discusses how it will deliver broad access to a world-class capability in metabolic phenotyping using UPLC and high resolution MS systems from Waters.
Escalating Cancer Research through Automated RNASeq Sample Preparation from Archival FFPE Tissue Specimens
This poster describes a high throughput automated ScripSeq RNA library preparation method for archival prostate cancer FFPE tissue, utilizing Beckman Coulter’s Biomek FXP platform.
Extracellular Matrices: Innovative Cancer Research
In this exclusive video tour of the Cancer Research UK Beatson Institute, Prof. Jim Norman describes the current research taking place at the world-class cancer research facility, including cell cancer metabolism, cancer cell proliferation, and mechanisms of invasion and metathesis.
Phosphorylation Site Specific Aptamers for Cancer Biomarker Peptide Enrichment and Detection in Mass Spectrometry Based Proteomics
This application note shows the development of high-affinity aptamers against specific phosphorylated and unmodified peptide target sequences of certain cancer biomarkers of interest, utilizing Base Pair Biotechnologies patented, multiplexed “Systematic Evolution of Ligands by Exponential enrichment” (SELEX) approach.
Using Droplet Digital™ PCR for Cancer and Liquid Biopsy Studies
See how Bio-Rad’s Droplet Digital PCR technology is being used to identify cancer subtypes, optimize drug treatment plans, monitor residual disease, and study tumor evolution.
Detecting Phenotypical Subgroups in Breast Cancer using Multiplexed Protein Expression Analysis in Intact Tissue Sections
This application note demonstrates the ability of PerkinElmer’s Nuance® multiplex biomarker and Vectra® quantitative pathology imaging systems to capture cellular and sub-cellular expression details in an intact tissue architectural context.
The C-DiGit Blot Scanner Used in Breast Cancer Metastases Investigations
Read how the C-DiGit chemiluminescent Western blot scanner (LI-COR Biosciences) has been used to investigate uncommonly available specimens of matched fresh breast-to-brain metastases tissue and derived cells from patients undergoing neurosurgical resection.
Academic Drug Discovery for Cancer and Neuroscience Indications
Watch Professor John Atack, Director of Translational Drug Discovery at the University of Sussex, explain how his unit works in collaboration with the pharmaceutical industry in target identification and lead optimization, for Cancer and Neuroscience indications.
For more information see our Cancer Research Special Feature>>